VALO THERAPEUTICS OY has a total of 35 patent applications. It decreased the IP activity by 42.0%. Its first patent ever was published in 2015. It filed its patents most often in Australia, United Kingdom and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are REDVAX GMBH, NOVAVAX INC and AVEXIS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United Kingdom | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 4 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Japan | 2 | |
#10 | WIPO (World Intellectual Property Organization) | 2 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Cerullo Vincenzo | 24 |
#2 | Priha Petri | 13 |
#3 | Ylosmaki Erkko | 13 |
#4 | Ranki Tuuli | 13 |
#5 | Martins Beatriz | 12 |
#6 | Capasso Cristian | 12 |
#7 | Pesonen Sari | 11 |
#8 | Ylösmäki Erkko | 7 |
#9 | Hirvinen Mari | 5 |
#10 | Vincenzo Cerullo | 5 |
Publication | Filing date | Title |
---|---|---|
GB202013834D0 | PeptiVAX therapy | |
GB201804473D0 | Modified oncolytic adenoviruses | |
GB201804468D0 | PeptiCRAd Cancer Therapy | |
EP3145537A2 | Coated oncolytic adenoviruses for cancer vaccines |